НЕВРОЛОГИЧЕСКИЕ ОСЛОЖНЕНИЯ SARS-COV-2 И ОСОБЕННОСТИ ВЕДЕНИЯ ПАЦИЕНТОВ С НЕВРОЛОГИЧЕСКИМИ ЗАБОЛЕВАНИЯМИ В ПЕРИОД ПАНДЕМИИ
Обзорная статья
Дата публикации: июня 7, 2020
Ключевые слова
COVID–19
коронавирусная инфекция
пандемия
неврологические осложнения
коронавирусная инфекция
пандемия
неврологические осложнения
Как цитировать
[1]
В. И. Шмырев, С. М. Крыжановский, Е. Г. Демьяновская, и А. Д. Бриль, НЕВРОЛОГИЧЕСКИЕ ОСЛОЖНЕНИЯ SARS-COV-2 И ОСОБЕННОСТИ ВЕДЕНИЯ ПАЦИЕНТОВ С НЕВРОЛОГИЧЕСКИМИ ЗАБОЛЕВАНИЯМИ В ПЕРИОД ПАНДЕМИИ, КМКВ, вып. 2, сс. 28-35, июн. 2020.
Аннотация
Пандемия короновирусной инфекции (COVID–19), охватившая весь мир, привела к беспрецедентным организационным мероприятиям по контролю за распространением инфекции. Помимо карантинных мероприятий, активно идет поиск мишеней для терапевтического воздействия и прогнозирование ближайших и отдаленных последствий пандемии. Важными аспектами являются выбор правильной тактики и отслеживание развития ранних и отдаленных последствий неврологических осложнений COVID-19. В данной публикации авторы обобщают имеющиеся данные, приводят возможные проблемы, с которыми могут столкнуться неврологи после снижения активности пандемии. Анализ данных более ранних эпидемий короновирусной инфекции показал, что вероятнее всего в отсроченном периоде неврологи столкнутся с когнитивными и психоэмоциональными расстройствами и другими патологиями. Течение имеющихся неврологических заболеваний может обостриться, в связи с чем в публикации приводятся основные рекомендации по тактике ведения отдельных пациентов, разработанной зарубежными и отечественными специалистами.Литература
1. Cascella M. et al. Features, evaluation and treatment coronavirus (COVID-19) // StatPearls [Internet]. – StatPearls Publishing. 2020.
2. Middle East respiratory syndrome coronavirus (MERS-CoV). WHO; 2019. URL: https://www.who.int/news-room/fact-sheets/detail/middle-east-respiratory-syndrome-coronavirus-(mers-cov).
3. Li Y. C., Bai W. Z., Hashikawa T. The neuroinvasive potential of SARS‐CoV2 may play a role in the respiratory failure of COVID‐19 patients // Journal of medical virology. – 2020. doi: 10.1002/jmv.25728.
4. Sørensen M. D. et al. Severe Acute Respiratory Syndrome (SARS) Development of Diagnostics and Antivirals // Annals of the New York Academy of Sciences. – 2006. – V. 1067. – №. 1. – P. 500-505. doi: 10.1196/annals.1354.072.
5. Perlman S., Netland J. Coronaviruses post-SARS: update on replication and pathogenesis // Nature reviews microbiology. – 2009. – V. 7. – №. 6. – P. 439-450. doi: 10.1038/nrmicro2147.
6. Huang C. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China // The Lancet. – 2020. – V. 395. – №. 10223. – P. 497-506. doi: 10.1016/S0140-6736(20)30183-5.
7. Du Y. et al. Clinical features of 85 fatal cases of COVID-19 from Wuhan: A retrospective observational study // American Journal of Respiratory and Critical Care Medicine. – 2020. doi: 10.1164/rccm.202003-0543OC.
8. Zhang Q. L. et al. Detection of severe acute respiratory syndrome (SARS)-associated coronavirus RNA in autopsy tissues with in situ hybridization // Di 1 jun yi da xue xue bao= Academic journal of the first medical college of PLA. – 2003. – V. 23. – №. 11. – P. 1125-1127. doi: 10.1309/C0ED-U0RA-QBTX-BHCE.
9. Saad M. et al. Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia // International Journal of Infectious Diseases. – 2014. – V. 29. – P. 301-306. doi: 10.1016/j.ijid.2014.09.003.
10. Kim J. E. et al. Neurological complications during treatment of Middle East respiratory syndrome // Journal of Clinical Neurology. – 2017. – V. 13. – №. 3. – P. 227-233. doi: 10.3988/jcn.2017.13.3.227.
11. Sheng B. et al. The effects of disease severity use of corticosteroids and social factors on neuropsychiatric complaints in severe acute respiratory syndrome (SARS) patients at acute and convalescent phases // European psychiatry. – 2005. – V. 20. – №. 3. – P. 236-242. doi: 10.1016/j.eurpsy.2004.06.023.
12. Bohmwald K. et al. Neurologic alterations due to respiratory virus infections // Frontiers in cellular neuroscience. – 2018. – V. 12. – P. 386. doi: 10.3389/fncel.2018.00386.
13. Mao L. et al. Neurological manifestations of hospitalized patients with COVID-19 in Wuhan, China: a retrospective case series study // JAMA Neurol. – 2020. doi: 10.1001/jamaneurol.2020.1127.
14. Xiang P. et al. First case of 2019 novel coronavirus disease with Encephalitis // ChinaXiv. – 2020. – V. 202003. – P. 00015.
15. Wu Y. et al. Nervous system involvement after infection with COVID-19 and other coronaviruses // Brain, Behavior, and Immunity. – 2020. doi: 10.1016/j.bbi.2020.03.031.
16. Baig A. M. et al. Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host–virus interaction, and proposed neurotropic mechanisms // ACS chemical neuroscience. – 2020. doi: 10.1021/acschemneuro.0c00122.
17. Мартынов М. Ю. и др. Ведение пациентов с острыми нарушениями мозгового кровообращения в контексте пандемии COVID-19. Временные методические рекомендации. Версия 1. 06.04.2020 г. Министерство здравоохранения РФ. Москва; 2020. URL: https://static-0.rosminzdrav.ru/system/attachments/attaches/000/049/629/original/Временные_МР_COVID-19_03.03.2020_%28версия_3%29_6-6.pdf?1583255386
18. Lyden P. Temporary Emergency Guidance to US Stroke Centers During the COVID-19 Pandemic On Behalf of the AHA/ASA Stroke Council Leadership // Stroke. – 2020. doi: 10.1161/STROKEAHA.120.030023.
19. Барбараш О. Л. и др. Руководство по диагностике и лечению болезней системы кровообращения (БСК) в контексте пандемии COVID-19 (краткая версия).
20. Global COVID-19 advice for people with MS. MS International Federation; 2020. URL: http://www.msif.org/wp-content/uploads/2020/03/MSIF-Global-advice-on-COVID-19-for-people-with-MS.docx-1.pdf
21. Association of British Neurologists Guidance on COVID-19 for people with neurological conditions, their doctors and carers. Version 3, 22 March 2020. The ABN Executive in association with subspecialist Advisory groups; 2020. URL: https://cdn.ymaws.com/www.theabn.org/resource/collection/6750BAE6-4CBC-4DDB-A684-116E03BFE634/ABN_Guidance_on_DMTs_for_MS_and_COVID19.pdf.
22. Poyiadji N. et al. COVID-19–associated acute hemorrhagic necrotizing encephalopathy: CT and MRI features // Radiology. – 2020. – P. 201187. doi: 10.1148/radiol.2020201187.
23. COVID-19. General advice for persons with epilepsy. March 30, 2020. ERN epicare steering committee; 2020. URL: https://epi-care.eu/wp-content/uploads/2020/04/COVID-19-and-Epilepsy_ERN-EpiCARE_Recommendations_ENGLISH.pdf.
24. Wiebe S. Letter from the president.March 24, 2020. International league against epilepsy; 2020. URL: https://www.ilae.org/files/dmfile/COVID-Letter-from-the-presidentMar-2020.pdf.
25. Covid-19 and people with neuromuscular disorders: World Muscle Society position and advice. World Muscle Society position and advice; 2020. URL: https://www.worldmusclesociety.org/files/COVID19/2020-04-02/2020-04-02-WMS-Covid-19-advice.pdf.
2. Middle East respiratory syndrome coronavirus (MERS-CoV). WHO; 2019. URL: https://www.who.int/news-room/fact-sheets/detail/middle-east-respiratory-syndrome-coronavirus-(mers-cov).
3. Li Y. C., Bai W. Z., Hashikawa T. The neuroinvasive potential of SARS‐CoV2 may play a role in the respiratory failure of COVID‐19 patients // Journal of medical virology. – 2020. doi: 10.1002/jmv.25728.
4. Sørensen M. D. et al. Severe Acute Respiratory Syndrome (SARS) Development of Diagnostics and Antivirals // Annals of the New York Academy of Sciences. – 2006. – V. 1067. – №. 1. – P. 500-505. doi: 10.1196/annals.1354.072.
5. Perlman S., Netland J. Coronaviruses post-SARS: update on replication and pathogenesis // Nature reviews microbiology. – 2009. – V. 7. – №. 6. – P. 439-450. doi: 10.1038/nrmicro2147.
6. Huang C. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China // The Lancet. – 2020. – V. 395. – №. 10223. – P. 497-506. doi: 10.1016/S0140-6736(20)30183-5.
7. Du Y. et al. Clinical features of 85 fatal cases of COVID-19 from Wuhan: A retrospective observational study // American Journal of Respiratory and Critical Care Medicine. – 2020. doi: 10.1164/rccm.202003-0543OC.
8. Zhang Q. L. et al. Detection of severe acute respiratory syndrome (SARS)-associated coronavirus RNA in autopsy tissues with in situ hybridization // Di 1 jun yi da xue xue bao= Academic journal of the first medical college of PLA. – 2003. – V. 23. – №. 11. – P. 1125-1127. doi: 10.1309/C0ED-U0RA-QBTX-BHCE.
9. Saad M. et al. Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia // International Journal of Infectious Diseases. – 2014. – V. 29. – P. 301-306. doi: 10.1016/j.ijid.2014.09.003.
10. Kim J. E. et al. Neurological complications during treatment of Middle East respiratory syndrome // Journal of Clinical Neurology. – 2017. – V. 13. – №. 3. – P. 227-233. doi: 10.3988/jcn.2017.13.3.227.
11. Sheng B. et al. The effects of disease severity use of corticosteroids and social factors on neuropsychiatric complaints in severe acute respiratory syndrome (SARS) patients at acute and convalescent phases // European psychiatry. – 2005. – V. 20. – №. 3. – P. 236-242. doi: 10.1016/j.eurpsy.2004.06.023.
12. Bohmwald K. et al. Neurologic alterations due to respiratory virus infections // Frontiers in cellular neuroscience. – 2018. – V. 12. – P. 386. doi: 10.3389/fncel.2018.00386.
13. Mao L. et al. Neurological manifestations of hospitalized patients with COVID-19 in Wuhan, China: a retrospective case series study // JAMA Neurol. – 2020. doi: 10.1001/jamaneurol.2020.1127.
14. Xiang P. et al. First case of 2019 novel coronavirus disease with Encephalitis // ChinaXiv. – 2020. – V. 202003. – P. 00015.
15. Wu Y. et al. Nervous system involvement after infection with COVID-19 and other coronaviruses // Brain, Behavior, and Immunity. – 2020. doi: 10.1016/j.bbi.2020.03.031.
16. Baig A. M. et al. Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host–virus interaction, and proposed neurotropic mechanisms // ACS chemical neuroscience. – 2020. doi: 10.1021/acschemneuro.0c00122.
17. Мартынов М. Ю. и др. Ведение пациентов с острыми нарушениями мозгового кровообращения в контексте пандемии COVID-19. Временные методические рекомендации. Версия 1. 06.04.2020 г. Министерство здравоохранения РФ. Москва; 2020. URL: https://static-0.rosminzdrav.ru/system/attachments/attaches/000/049/629/original/Временные_МР_COVID-19_03.03.2020_%28версия_3%29_6-6.pdf?1583255386
18. Lyden P. Temporary Emergency Guidance to US Stroke Centers During the COVID-19 Pandemic On Behalf of the AHA/ASA Stroke Council Leadership // Stroke. – 2020. doi: 10.1161/STROKEAHA.120.030023.
19. Барбараш О. Л. и др. Руководство по диагностике и лечению болезней системы кровообращения (БСК) в контексте пандемии COVID-19 (краткая версия).
20. Global COVID-19 advice for people with MS. MS International Federation; 2020. URL: http://www.msif.org/wp-content/uploads/2020/03/MSIF-Global-advice-on-COVID-19-for-people-with-MS.docx-1.pdf
21. Association of British Neurologists Guidance on COVID-19 for people with neurological conditions, their doctors and carers. Version 3, 22 March 2020. The ABN Executive in association with subspecialist Advisory groups; 2020. URL: https://cdn.ymaws.com/www.theabn.org/resource/collection/6750BAE6-4CBC-4DDB-A684-116E03BFE634/ABN_Guidance_on_DMTs_for_MS_and_COVID19.pdf.
22. Poyiadji N. et al. COVID-19–associated acute hemorrhagic necrotizing encephalopathy: CT and MRI features // Radiology. – 2020. – P. 201187. doi: 10.1148/radiol.2020201187.
23. COVID-19. General advice for persons with epilepsy. March 30, 2020. ERN epicare steering committee; 2020. URL: https://epi-care.eu/wp-content/uploads/2020/04/COVID-19-and-Epilepsy_ERN-EpiCARE_Recommendations_ENGLISH.pdf.
24. Wiebe S. Letter from the president.March 24, 2020. International league against epilepsy; 2020. URL: https://www.ilae.org/files/dmfile/COVID-Letter-from-the-presidentMar-2020.pdf.
25. Covid-19 and people with neuromuscular disorders: World Muscle Society position and advice. World Muscle Society position and advice; 2020. URL: https://www.worldmusclesociety.org/files/COVID19/2020-04-02/2020-04-02-WMS-Covid-19-advice.pdf.